Home Infusion Therapy Market is Expected to Grow at 7.5% by 2031. Home infusion therapy refers to administration of biological and drugs in patient’s home, wither by patient themselves, family, nurse and others. Home infusion services include patient training and education, administration, care coordination, pharmacy services and others. These services and supplies are usually provided by physicians and pharmacy staff, where initially, the patient picks up medications form physician’s office. Nursing services for home care are also provided through agencies.
Geriatric population is the largest consumer of home infusion therapy. As the global population is ageing, this population possesses a high risk and susceptibility of this population group to develop chronic conditions that require infusion therapy. Growing demand for home healthcare by disabled patient group will additionally widen the base for home infusion therapy. Augmenting use of home infusion therapy also results in reduction in hospital readmission and in-patient stay, thus containing healthcare costs. Home infusion therapy is also instrumental in reducing the risk of contracting nosocomial infection thus presenting a potential market penetration opportunity.
Key players identified for the healthcare analytical testing market include but are not limited to:
CVS/Coram
Option Care Health
CareFusion Corporation
BriovaRx/Diplomat (UnitedHealth Optum)
PharMerica
Fresenius Kabi
ICU Medical, Inc.
B. Braun Melsungen AG
Baxter
BD
Caesarea Medical Electronics
Smiths Medical
Terumo Corporation
JMS Co. Ltd.
Historical & Forecast Period
This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Home Infusion Therapy market are as follows:
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
ATTRIBUTE | DETAILS |
---|---|
Research Period | 2022-2032 |
Base Year | 2023 |
Forecast Period | 2024-2032 |
Historical Year | 2022 |
Unit | USD Million |
Segmentation | |
Product Type
| |
Therapy Type
| |
Route of Administration
| |
Region Segment (2022-2032; US$ Million)
|
Key questions answered in this report